基于假体的乳房再造是否影响乳房切除术后放疗的临床结局?
该回顾性队列研究纳入1998年1月1日至2011年12月31日接受乳房切除术后放疗的1015例乳腺癌患者,其中111例接受基于假体的乳房再造,904例未接受乳房再造。多变量Cox回归分析显示,两组局部区域无复发生存(HR 0.852,P=0.771)和总生存(HR 1.317,P=0.246)均无显著差异。
要点
- 基于假体的乳房再造组与未再造组的局部区域复发率分别为3.6%和3.8%。
- 多变量分析显示两组局部区域无复发生存无显著差异(HR 0.852,P=0.771)。
- 两组总生存无显著差异(HR 1.317,P=0.246)。
核心结论
- 基于假体的乳房再造似乎未对乳房切除术后放疗的局部区域无复发生存和总生存产生显著不良影响。
研究设计与样本
- 回顾性队列研究,纳入1998年1月1日至2011年12月31日接受乳房切除术后放疗的乳腺癌患者1015例,其中111例接受基于假体的乳房再造,904例未接受乳房再造,采用多变量Cox比例风险分析控制混杂因素。
主要发现
- 未再造组904例中34例(3.8%)出现局部区域复发,再造组111例中4例(3.6%)出现局部区域复发。
- 多变量生存分析显示,未再造组与再造组局部区域无复发生存无显著差异(HR 0.852,P=0.771)。
- 多变量生存分析显示,未再造组与再造组总生存无显著差异(HR 1.317,P=0.246)。
关键数值与推荐
- 局部区域无复发生存HR 0.852(P=0.771),未达统计学显著。
- 总生存HR 1.317(P=0.246),未达统计学显著。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the last 5 decades, there has been significant advancement of breast reconstruction and postmastectomy radiotherapy for breast cancer care. There has been concern that breast reconstruction may adversely affect the efficacy of postmastectomy radiotherapy. This, however, has not been proven by clear clinical evidence. METHODS: By comparing the locoregional recurrence rates and overall survival after postmastectomy radiotherapy between those with and without prosthesis-based breast reconstruction, a retrospective cohort study of the breast cancer patients was done. Multivariable Cox proportional hazards analysis was used to control the confounding factors. RESULTS: From January 1, 1998 to December 31, 2011, 1015 patients receiving postmastectomy radiotherapy were identified. Among them, 111 patients had prosthesis-based breast reconstruction, and the other 904 did not have breast reconstruction. Thirty-four of 904 (3.8%) patients in the nonreconstructed group and 4 of 111 (3.6%) patients in the reconstructed group developed locoregional recurrence. Multivariable survival analysis found no significant difference both in locoregional recurrence-free survival (hazard ratio, 0.852; P = 0.771) and in overall survival (hazard ratio = 1.317; P = 0.246) between the nonreconstructed group and reconstructed group. CONCLUSIONS: Although postmastectomy radiotherapy has been shown to affect the surgical and cosmetic outcomes of breast reconstruction, prosthesis-based breast reconstruction does not seem to have significant adverse impacts on the locoregional recurrence-free survival and overall survival of postmastectomy radiotherapy.
引用
- Chen CF, Hung CF, Lin SF, et al. Does Prosthesis-Based Breast Reconstruction Affect the Clinical Outcome of Postmastectomy Radiotherapy? Ann Plast Surg. 2018. PMID: 29369903. doi:10.1097/SAP.0000000000001286
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。